Lantheus Holdings, Inc. Line of Credit, Current
Lantheus Holdings, Inc. (LNTH) had Line of Credit, Current of $0 as of 2019-03-31, per its 10-Q filed 2019-04-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LinesOfCreditCurrent · last filed 2019-04-30
- 2019-03-31: Line of Credit, Current $0.00.
- 2018-12-31: Line of Credit, Current $0.00.
- 2018-09-30: Line of Credit, Current $0.00.
- 2018-06-30: Line of Credit, Current $0.00.
| Period end | Line of Credit, Current |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-04-30 |
| 2018-12-31 | $0.00 10-Q · filed 2019-04-30 |
| 2018-09-30 | $0.00 10-Q · filed 2018-10-30 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-20 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-01 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-02 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-26 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-03 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 |
| 2014-12-31 | $8.00M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |